Endodiabesity

The North West of England Endocrinology, Diabetes and Obesity Newsletter

Which oral hypoglycaemic for gestational diabetes?

Posted by Akheel Syed on 23 January, 2015

“Latest evidence favours metformin over glibenclamide, but there’s more work to do on both agents.”

Read all about it in The BMJ

Editorial by David Sacks, BMJ 2015;350:h177.

Systematic review and meta-analysis by Montserrat Balsells et al., BMJ 2015;350:h102

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s